Breast Cancer News and Research

Latest Breast Cancer News and Research

Breast cancer subtypes are different diseases

There is a biological distinction between breast cancers that depend on hormones and those that do not, according to research published in PLoS Genetics (Friday).

26 Apr 2008

FDA approves Actonel (risedronate sodium) for postmenopausal osteoporosis

The U.S. Food and Drug Administration (FDA) approved a new once-a-month dose (150 mg) of Actonel (risedronate sodium) tablets for the treatment and prevention of postmenopausal osteoporosis. Actonel is approved to reduce the risk of fractures in postmenopausal women with osteoporosis.

24 Apr 2008

Coffee protects some women against breast cancer

Depending on which variant of a certain gene a woman has, a coffee consumption rate of at least two-three cups a day can either reduce the total risk of developing breast cancer or delay the onset of cancer. This is shown in new research from Lund University and Malmo University in Sweden.

24 Apr 2008

Breast cancer subtypes originate from different biological pathways

There is a biological distinction between breast cancers that depend on hormones and those that do not, according to research published Friday, April 25th in the open-access journal PLoS Genetics.

24 Apr 2008

Reconstruction innovations for breast cancer patients

Lumpectomy or breast conservation surgery is the most common type of breast cancer surgery currently performed. A benefit of the surgery is that only part of the breast is removed, but a drawback can be the resulting physical appearance of the breast, which may be disfigured, dented or uneven.

23 Apr 2008

Discovery of new cell targets for preventing growth of breast and other tumors

Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.

23 Apr 2008

Discovery of gene that may influence metastasis risk in breast cancer

Researchers have identified a pattern of gene activity in mice that may help to predict individual risk for breast cancer metastasis and survival in humans. A single gene, called bromodomain 4 (Brd4), regulates the expression of this pattern, also called a signature.

22 Apr 2008

Seeking quality of life for cancer sufferers

The Faculty of Health Sciences at the University of Sydney been awarded funding for a new study with the potential to improve the quality of life for many breast cancer sufferers.

22 Apr 2008

Combo of Herceptin and chemo a cure for breast cancer

The latest research has shown that the combination of Herceptin and chemotherapy drugs is successful in treating women with aggressive breast cancer.

22 Apr 2008

Vitamin D protects women from breast cancer

The connection between vitamin D levels and certain forms of cancer has been suspected for some time but now German researchers have come up with clear proof of the link.

21 Apr 2008

Managing the care of breast cancer in patients 80 years of age and older

According to researchers at The University of Texas M. D. Anderson Cancer Center, mammography, the gold-standard for breast cancer screening and early detection, has shown to significantly reduce the risk of being diagnosed with advanced stage breast cancer in women over the age of 80, an age group currently without clear guidelines recommending regular screenings.

21 Apr 2008

British volunteers needed to help bring cure for cancer closer

Researchers, who are in the process of developing a blood test that may diagnose breast cancer up to four years earlier than a mammogram, need the help of thousands of people living in the East Midlands.

21 Apr 2008

Study shows many cancer survivors do little exercise and are overweight

A new study by Canadian researchers has revealed that not only are many cancer survivors inactive, some are also obese and this could have a negative affect on the control of their disease.

21 Apr 2008

Genentech updates on phase III study of Avastin plus chemo in first-line, advanced, non-squamous, non-small cell lung cancer

Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).

21 Apr 2008

Obesity, inactivity as common among cancer survivors as rest of Canadians

New research supported by the Canadian Cancer Society shows that many cancer survivors in Canada are overweight and inactive, which could put them at risk for health problems, including their cancer returning.

21 Apr 2008

Physical activity and obesity in Canadian cancer survivors

A new study reveals that many cancer survivors are inactive and obese, which may negatively affect the control of their disease.

21 Apr 2008

Discovery of method for clamping down on a cancer-promoting enzyme

There are many pathways that allow an errant gene to turn a cell cancerous, and a number of these pathways go through a single enzyme called the p21-activated kinase 1, or PAK1.

18 Apr 2008

Vitamin D and the risk of developing breast cancer

A connection between vitamin D level and the risk of developing breast cancer has been implicated for a long time, but its clinical relevance had not yet been proven.

18 Apr 2008

Gentle yoga enhances quality of life for breast cancer patients

Researchers at Wake Forest University School of Medicine have shown that restorative yoga (RY), a very gentle form of yoga that can be practiced even when ill or fatigued, can improve the quality of life and emotional status of women with breast cancer

18 Apr 2008

Countries could save millions of Euros a year if follow-ups for breast cancer patients were led by specialist nurses rather than physicians

Follow-up care for breast cancer patients costs less if it is conducted by nurses rather than physicians, yet there is no difference in the patients' anxiety, depression, satisfaction or outcome, according to research presented today (Friday) at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.

18 Apr 2008